Wojcicki: How 23andMe Disrupts Health Care With DNA
Nov. 26 (Bloomberg) -- Anne Wojcicki, CEO & co-founder at 23andMe, discusses the company’s battle with the FDA over their $99 DNA testing product and the company’s plans for growth using big data. She speaks on Bloomberg Television’s “Market Makers.”
Most Recent Videos
The Natural Catastrophes Hurting Swiss Re's Profits
54:44 - Swiss Re AG, the world’s biggest reinsurer, said profit fell in the second-quarter as the company paid more for catastrophe claims including earthquakes in Japan and forest fires in Canada. Net income declined to $637 million from $820 million a year earlier, the Zurich-based company said in a statement on Friday. That beat the $605 million average estimate of nine analysts in a Bloomberg survey. Chief Financial Officer David Cole discusses with Bloomberg's Francine Lacqua on "The Pulse."